

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.92310645 |
| 2 | polyketide metabolic process (GO:0030638) | 4.49031043 |
| 3 | doxorubicin metabolic process (GO:0044598) | 4.49031043 |
| 4 | daunorubicin metabolic process (GO:0044597) | 4.49031043 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.41975714 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.28689930 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.28689930 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.28689930 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.28689930 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.28689930 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.28689930 |
| 12 | superoxide anion generation (GO:0042554) | 4.23180605 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.12106392 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.12106392 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06236009 |
| 16 | response to peptidoglycan (GO:0032494) | 4.04499047 |
| 17 | respiratory burst (GO:0045730) | 4.01336585 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98559183 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.97767700 |
| 20 | neutrophil activation (GO:0042119) | 3.85811776 |
| 21 | granulocyte activation (GO:0036230) | 3.82188646 |
| 22 | leukocyte aggregation (GO:0070486) | 3.80065910 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.72439333 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.71576093 |
| 25 | defense response to protozoan (GO:0042832) | 3.57989122 |
| 26 | positive regulation of antigen processing and presentation (GO:0002579) | 3.47193118 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.42149712 |
| 28 | tolerance induction (GO:0002507) | 3.41174725 |
| 29 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.39463046 |
| 30 | response to muramyl dipeptide (GO:0032495) | 3.37710675 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.36510664 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.32311420 |
| 33 | positive regulation of heat generation (GO:0031652) | 3.30327561 |
| 34 | germinal center formation (GO:0002467) | 3.29756057 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29442383 |
| 36 | regulation of fever generation (GO:0031620) | 3.29158701 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.26615075 |
| 38 | detection of bacterium (GO:0016045) | 3.25268749 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.23590619 |
| 40 | response to protozoan (GO:0001562) | 3.20986690 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.20496794 |
| 42 | B cell mediated immunity (GO:0019724) | 3.18290700 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 3.17016833 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16166641 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16072605 |
| 46 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15666564 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14565436 |
| 48 | positive regulation of mast cell activation (GO:0033005) | 3.14175844 |
| 49 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.13773892 |
| 50 | T cell migration (GO:0072678) | 3.13322906 |
| 51 | monocyte chemotaxis (GO:0002548) | 3.13296713 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.13040664 |
| 53 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.11847035 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.11776972 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 3.11687116 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.11363893 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.10952141 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.10885142 |
| 59 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.10622469 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09636580 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.07968053 |
| 62 | response to host immune response (GO:0052572) | 3.07968053 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07785914 |
| 64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06657332 |
| 65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06196082 |
| 66 | eosinophil chemotaxis (GO:0048245) | 3.04957005 |
| 67 | cellular response to interferon-beta (GO:0035458) | 3.03958511 |
| 68 | positive regulation of defense response to virus by host (GO:0002230) | 3.03827665 |
| 69 | macrophage activation (GO:0042116) | 3.03638407 |
| 70 | positive regulation of interleukin-10 production (GO:0032733) | 3.02530003 |
| 71 | detection of external biotic stimulus (GO:0098581) | 3.02129756 |
| 72 | myeloid dendritic cell differentiation (GO:0043011) | 3.02104799 |
| 73 | interferon-gamma production (GO:0032609) | 3.01433867 |
| 74 | cellular response to exogenous dsRNA (GO:0071360) | 3.01043310 |
| 75 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.99776096 |
| 76 | regulation of chemokine biosynthetic process (GO:0045073) | 2.99329735 |
| 77 | neutrophil mediated immunity (GO:0002446) | 2.98771029 |
| 78 | regulation of activation of Janus kinase activity (GO:0010533) | 2.97699807 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 2.96809811 |
| 80 | mature B cell differentiation (GO:0002335) | 2.96728539 |
| 81 | negative regulation of interleukin-6 production (GO:0032715) | 2.96677980 |
| 82 | microglial cell activation (GO:0001774) | 2.94777143 |
| 83 | negative regulation of mast cell activation (GO:0033004) | 2.92429492 |
| 84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91603036 |
| 85 | positive regulation of interferon-alpha production (GO:0032727) | 2.90810205 |
| 86 | T-helper 1 type immune response (GO:0042088) | 2.90798779 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89705100 |
| 88 | response to host (GO:0075136) | 2.89705100 |
| 89 | response to host defenses (GO:0052200) | 2.89705100 |
| 90 | positive regulation of interleukin-17 production (GO:0032740) | 2.89563101 |
| 91 | regulation of interleukin-17 production (GO:0032660) | 2.88531821 |
| 92 | mast cell activation (GO:0045576) | 2.87738969 |
| 93 | cellular extravasation (GO:0045123) | 2.87387558 |
| 94 | leukocyte degranulation (GO:0043299) | 2.87313752 |
| 95 | detection of other organism (GO:0098543) | 2.86826482 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86336921 |
| 97 | cellular response to type I interferon (GO:0071357) | 2.85852022 |
| 98 | type I interferon signaling pathway (GO:0060337) | 2.85852022 |
| 99 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85290983 |
| 100 | positive thymic T cell selection (GO:0045059) | 2.84784705 |
| 101 | response to type I interferon (GO:0034340) | 2.84636665 |
| 102 | negative regulation of interleukin-17 production (GO:0032700) | 2.84632858 |
| 103 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84555018 |
| 104 | regulation of interferon-alpha production (GO:0032647) | 2.83883439 |
| 105 | regulation of mast cell activation (GO:0033003) | 2.83569884 |
| 106 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.82741990 |
| 107 | myeloid leukocyte activation (GO:0002274) | 2.82654676 |
| 108 | negative thymic T cell selection (GO:0045060) | 2.82371116 |
| 109 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81843497 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81843497 |
| 111 | regulation of interleukin-12 production (GO:0032655) | 2.81216002 |
| 112 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.79978250 |
| 113 | positive regulation of interferon-gamma production (GO:0032729) | 2.78000610 |
| 114 | negative regulation of innate immune response (GO:0045824) | 2.77938642 |
| 115 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.77797922 |
| 116 | eosinophil migration (GO:0072677) | 2.77135145 |
| 117 | positive regulation of interleukin-12 production (GO:0032735) | 2.76640516 |
| 118 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.76300431 |
| 119 | positive regulation of isotype switching (GO:0045830) | 2.75232449 |
| 120 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.74850564 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.74829836 |
| 122 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.74763569 |
| 123 | positive regulation of B cell mediated immunity (GO:0002714) | 2.74763569 |
| 124 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.74439635 |
| 125 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73808096 |
| 126 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.73552071 |
| 127 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.73210631 |
| 128 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73189910 |
| 129 | regulation of B cell differentiation (GO:0045577) | 2.72914189 |
| 130 | negative regulation of growth of symbiont in host (GO:0044130) | 2.72791302 |
| 131 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.72791302 |
| 132 | regulation of growth of symbiont in host (GO:0044126) | 2.72791302 |
| 133 | negative T cell selection (GO:0043383) | 2.68090314 |
| 134 | positive regulation of interferon-beta production (GO:0032728) | 2.68005645 |
| 135 | regulation of germinal center formation (GO:0002634) | 2.67904323 |
| 136 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67080851 |
| 137 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.66222359 |
| 138 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.65989351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.44608657 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.36550938 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.20083767 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.30168466 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.93876498 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.47274110 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.44000629 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.38953974 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31180134 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00027667 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81599842 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63112244 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61459001 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57834341 |
| 15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.57671130 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32149813 |
| 17 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.30977955 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07771602 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03847193 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99899517 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99204014 |
| 22 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96251857 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94394388 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.91368519 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90949890 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.89405168 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88511491 |
| 28 | * MYC_22102868_ChIP-Seq_BL_Human | 1.86639304 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.81610845 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.80939134 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75806779 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74845130 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71138840 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.69119945 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69101974 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.65380450 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64882763 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64263261 |
| 39 | * MYB_26560356_Chip-Seq_TH2_Human | 1.62653474 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57223465 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55966454 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55440334 |
| 43 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53709897 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52942424 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52027955 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49269845 |
| 47 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.48773692 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45593090 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43106527 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42179464 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42174356 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40265149 |
| 53 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40256978 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40206251 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40105723 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38241608 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36445964 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32186367 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30733878 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29918970 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27492408 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27302804 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27231404 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25951194 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.25866118 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25261229 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24463470 |
| 68 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.22493954 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21214771 |
| 70 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.20442280 |
| 71 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19322036 |
| 72 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18516669 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17050727 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16747712 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16492768 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15254627 |
| 77 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15150028 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14801166 |
| 79 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13246721 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12378923 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11906486 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10314388 |
| 83 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.09408345 |
| 84 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08707123 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08237673 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07784414 |
| 87 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.07126160 |
| 88 | * P300_27268052_Chip-Seq_Bcells_Human | 1.07027794 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06927182 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06801585 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05973954 |
| 92 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05374730 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05029783 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04764767 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03904533 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03600727 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02071050 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01934497 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00781805 |
| 100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99745395 |
| 101 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99709898 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98660206 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98621447 |
| 104 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.98367471 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97778205 |
| 106 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97488082 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96939006 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96518399 |
| 109 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96146199 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96092960 |
| 111 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96012508 |
| 112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95597281 |
| 113 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95556178 |
| 114 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.95256443 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95251584 |
| 116 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95027281 |
| 117 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94006989 |
| 118 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.93631968 |
| 119 | * MAF_26560356_Chip-Seq_TH1_Human | 0.92603012 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92555370 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92190471 |
| 122 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92126821 |
| 123 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.92012201 |
| 124 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91727894 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91569033 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91459087 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91412711 |
| 128 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91392164 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91057736 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90548271 |
| 131 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89703937 |
| 132 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.89614827 |
| 133 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89545946 |
| 134 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88907451 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88842845 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88806922 |
| 137 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88429543 |
| 138 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88279212 |
| 139 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.87279455 |
| 140 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.87270612 |
| 141 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83466753 |
| 142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83233253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.37941941 |
| 2 | MP0009785_altered_susceptibility_to | 3.41599641 |
| 3 | MP0005671_abnormal_response_to | 3.39665093 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.39612111 |
| 5 | MP0003436_decreased_susceptibility_to | 3.19917692 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.19258448 |
| 7 | MP0005387_immune_system_phenotype | 3.06042305 |
| 8 | MP0001790_abnormal_immune_system | 3.06042305 |
| 9 | MP0002419_abnormal_innate_immunity | 2.96139839 |
| 10 | MP0003724_increased_susceptibility_to | 2.93443715 |
| 11 | MP0005025_abnormal_response_to | 2.84336135 |
| 12 | MP0001800_abnormal_humoral_immune | 2.79839843 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.76779414 |
| 14 | MP0000685_abnormal_immune_system | 2.72713665 |
| 15 | MP0002723_abnormal_immune_serum | 2.67390207 |
| 16 | MP0006082_CNS_inflammation | 2.54701834 |
| 17 | MP0001819_abnormal_immune_cell | 2.44327488 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.44005140 |
| 19 | MP0003303_peritoneal_inflammation | 2.39258512 |
| 20 | MP0002405_respiratory_system_inflammati | 2.05966552 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.05922155 |
| 22 | MP0001853_heart_inflammation | 1.95950961 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 1.95322952 |
| 24 | MP0004510_myositis | 1.94490123 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.87208793 |
| 26 | MP0000716_abnormal_immune_system | 1.85522462 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.81753666 |
| 28 | MP0000015_abnormal_ear_pigmentation | 1.77427706 |
| 29 | MP0002398_abnormal_bone_marrow | 1.77355213 |
| 30 | MP0003136_yellow_coat_color | 1.73987870 |
| 31 | MP0005310_abnormal_salivary_gland | 1.72209786 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.71598577 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.69309010 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.68757214 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.60969293 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.56674861 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.52470961 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.49514846 |
| 39 | MP0009764_decreased_sensitivity_to | 1.49001008 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.48184581 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.46088421 |
| 42 | MP0002429_abnormal_blood_cell | 1.44202186 |
| 43 | MP0004381_abnormal_hair_follicle | 1.42167606 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.41665206 |
| 45 | MP0002006_tumorigenesis | 1.38059191 |
| 46 | MP0008004_abnormal_stomach_pH | 1.37184201 |
| 47 | MP0002933_joint_inflammation | 1.35777093 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.33470773 |
| 49 | MP0002722_abnormal_immune_system | 1.32871074 |
| 50 | MP0003195_calcinosis | 1.31773345 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.26096842 |
| 52 | MP0002132_abnormal_respiratory_system | 1.26025875 |
| 53 | MP0008260_abnormal_autophagy | 1.25516474 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.23966130 |
| 55 | MP0008469_abnormal_protein_level | 1.23097579 |
| 56 | MP0003448_altered_tumor_morphology | 1.22896755 |
| 57 | MP0003646_muscle_fatigue | 1.21745060 |
| 58 | MP0004742_abnormal_vestibular_system | 1.21521827 |
| 59 | MP0001873_stomach_inflammation | 1.18429153 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.18345451 |
| 61 | MP0004947_skin_inflammation | 1.17343231 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.15284530 |
| 63 | MP0009840_abnormal_foam_cell | 1.14545581 |
| 64 | MP0005409_darkened_coat_color | 1.12795784 |
| 65 | MP0002102_abnormal_ear_morphology | 1.10590086 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.09858618 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.08059991 |
| 68 | MP0005171_absent_coat_pigmentation | 1.07016409 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.06162714 |
| 70 | MP0000858_altered_metastatic_potential | 1.05742377 |
| 71 | MP0000490_abnormal_crypts_of | 1.00199881 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.00187671 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.00155937 |
| 74 | MP0003045_fibrosis | 0.99355264 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.97923598 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.97610761 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.96832464 |
| 78 | MP0001188_hyperpigmentation | 0.95380848 |
| 79 | MP0000343_altered_response_to | 0.94938169 |
| 80 | MP0001851_eye_inflammation | 0.93954444 |
| 81 | MP0005257_abnormal_intraocular_pressure | 0.93889530 |
| 82 | MP0005390_skeleton_phenotype | 0.93340536 |
| 83 | MP0000604_amyloidosis | 0.91738305 |
| 84 | MP0009763_increased_sensitivity_to | 0.90889869 |
| 85 | MP0008057_abnormal_DNA_replication | 0.89844963 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.87869148 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.87343106 |
| 88 | MP0003866_abnormal_defecation | 0.85621207 |
| 89 | MP0003828_pulmonary_edema | 0.83877644 |
| 90 | MP0001501_abnormal_sleep_pattern | 0.82930832 |
| 91 | MP0005451_abnormal_body_composition | 0.80340266 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.79213433 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.78413944 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 0.75484800 |
| 95 | MP0003795_abnormal_bone_structure | 0.74955330 |
| 96 | MP0001663_abnormal_digestive_system | 0.74945564 |
| 97 | MP0002653_abnormal_ependyma_morphology | 0.74443981 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.73665421 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.73483631 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.73483631 |
| 101 | MP0005377_hearing/vestibular/ear_phenot | 0.72438241 |
| 102 | MP0003878_abnormal_ear_physiology | 0.72438241 |
| 103 | MP0004130_abnormal_muscle_cell | 0.72267407 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.70848278 |
| 105 | MP0005164_abnormal_response_to | 0.69550314 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.68170008 |
| 107 | MP0005166_decreased_susceptibility_to | 0.67086568 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.66976686 |
| 109 | MP0000249_abnormal_blood_vessel | 0.66798183 |
| 110 | MP0000371_diluted_coat_color | 0.64390653 |
| 111 | MP0004043_abnormal_pH_regulation | 0.64097284 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.63924764 |
| 113 | MP0000920_abnormal_myelination | 0.63613010 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.62120359 |
| 115 | MP0004883_abnormal_blood_vessel | 0.61851389 |
| 116 | MP0000566_synostosis | 0.60351928 |
| 117 | MP0003075_altered_response_to | 0.59520523 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.59486750 |
| 119 | MP0008058_abnormal_DNA_repair | 0.59332228 |
| 120 | MP0009278_abnormal_bone_marrow | 0.58500041 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.58424797 |
| 122 | MP0002254_reproductive_system_inflammat | 0.58337708 |
| 123 | MP0002163_abnormal_gland_morphology | 0.58017490 |
| 124 | MP0002019_abnormal_tumor_incidence | 0.56967975 |
| 125 | MP0005266_abnormal_metabolism | 0.55832064 |
| 126 | MP0006054_spinal_hemorrhage | 0.54604789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.67841829 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.50185230 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.90802742 |
| 4 | Stomatitis (HP:0010280) | 4.30065890 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.21127690 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.13012138 |
| 7 | Optic neuritis (HP:0100653) | 4.13012138 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.10657285 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.09026577 |
| 10 | Obstructive lung disease (HP:0006536) | 4.09026577 |
| 11 | Myositis (HP:0100614) | 4.05148016 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04107846 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.00030102 |
| 14 | Orchitis (HP:0100796) | 3.67163034 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.64947520 |
| 16 | Recurrent skin infections (HP:0001581) | 3.49442711 |
| 17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.49419111 |
| 18 | Chronic otitis media (HP:0000389) | 3.36544322 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35568134 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35568134 |
| 21 | Meningitis (HP:0001287) | 3.31426008 |
| 22 | Recurrent pneumonia (HP:0006532) | 3.29725164 |
| 23 | Vasculitis (HP:0002633) | 3.24266386 |
| 24 | Parakeratosis (HP:0001036) | 3.22221754 |
| 25 | Gingivitis (HP:0000230) | 3.12032175 |
| 26 | Recurrent viral infections (HP:0004429) | 2.98756561 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.97262495 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 2.82168642 |
| 29 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.81172502 |
| 30 | Agammaglobulinemia (HP:0004432) | 2.80969917 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 2.79476312 |
| 32 | Prostate neoplasm (HP:0100787) | 2.77350042 |
| 33 | Cheilitis (HP:0100825) | 2.76849196 |
| 34 | Increased IgE level (HP:0003212) | 2.71312641 |
| 35 | Pulmonary infiltrates (HP:0002113) | 2.69264505 |
| 36 | Increased IgM level (HP:0003496) | 2.66051110 |
| 37 | Recurrent lower respiratory tract infections (HP:0002783) | 2.65065904 |
| 38 | Cellulitis (HP:0100658) | 2.60792347 |
| 39 | Basal ganglia calcification (HP:0002135) | 2.59721718 |
| 40 | Epistaxis (HP:0000421) | 2.59184783 |
| 41 | Chromsome breakage (HP:0040012) | 2.55155647 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.51735606 |
| 43 | Increased serum ferritin (HP:0003281) | 2.44700532 |
| 44 | White forelock (HP:0002211) | 2.41640086 |
| 45 | Colitis (HP:0002583) | 2.40796067 |
| 46 | IgM deficiency (HP:0002850) | 2.39726216 |
| 47 | Recurrent sinusitis (HP:0011108) | 2.39630724 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39475782 |
| 49 | Chronic sinusitis (HP:0011109) | 2.39255533 |
| 50 | Chronic diarrhea (HP:0002028) | 2.38772174 |
| 51 | Hemoptysis (HP:0002105) | 2.38731476 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.38270958 |
| 53 | Clumsiness (HP:0002312) | 2.36916950 |
| 54 | Lymphopenia (HP:0001888) | 2.35891303 |
| 55 | Patchy hypopigmentation of hair (HP:0011365) | 2.33908490 |
| 56 | Purpura (HP:0000979) | 2.30833468 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.29254432 |
| 58 | Chest pain (HP:0100749) | 2.28371962 |
| 59 | Osteomyelitis (HP:0002754) | 2.27755235 |
| 60 | Urticaria (HP:0001025) | 2.25938302 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.23628381 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.21655218 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.21150508 |
| 64 | Anorexia (HP:0002039) | 2.20769457 |
| 65 | T lymphocytopenia (HP:0005403) | 2.19867503 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.19853759 |
| 67 | Petechiae (HP:0000967) | 2.18791482 |
| 68 | Leukocytosis (HP:0001974) | 2.16008288 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.15339549 |
| 70 | Pulmonary embolism (HP:0002204) | 2.15046292 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.13522162 |
| 72 | Episodic fever (HP:0001954) | 2.11711842 |
| 73 | Recurrent bronchitis (HP:0002837) | 2.11592154 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.09529613 |
| 75 | IgG deficiency (HP:0004315) | 2.09409323 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 2.09109547 |
| 77 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08583994 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.08262971 |
| 79 | Encephalitis (HP:0002383) | 2.08227763 |
| 80 | Keratitis (HP:0000491) | 2.06298971 |
| 81 | Congenital stationary night blindness (HP:0007642) | 2.04741995 |
| 82 | Duplicated collecting system (HP:0000081) | 2.02646206 |
| 83 | Eosinophilia (HP:0001880) | 2.02627628 |
| 84 | IgA deficiency (HP:0002720) | 2.02266002 |
| 85 | Stomach cancer (HP:0012126) | 2.01217981 |
| 86 | Abnormality of T cells (HP:0002843) | 2.00577697 |
| 87 | Nasal polyposis (HP:0100582) | 2.00107726 |
| 88 | Hypochromic anemia (HP:0001931) | 1.98538660 |
| 89 | Hematochezia (HP:0002573) | 1.98068373 |
| 90 | Abnormality of the renal collecting system (HP:0004742) | 1.96889521 |
| 91 | Pustule (HP:0200039) | 1.96431432 |
| 92 | Abnormality of DNA repair (HP:0003254) | 1.94191829 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93998076 |
| 94 | Thyroiditis (HP:0100646) | 1.93972719 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 1.93778773 |
| 96 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93644693 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92532599 |
| 98 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92532599 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92532599 |
| 100 | B lymphocytopenia (HP:0010976) | 1.92404135 |
| 101 | Abnormality of B cell number (HP:0010975) | 1.92404135 |
| 102 | Vertigo (HP:0002321) | 1.92305210 |
| 103 | Polyneuropathy (HP:0001271) | 1.92257229 |
| 104 | Periodontitis (HP:0000704) | 1.91090283 |
| 105 | Genetic anticipation (HP:0003743) | 1.90805667 |
| 106 | Albinism (HP:0001022) | 1.90619714 |
| 107 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.90314300 |
| 108 | Absent/shortened dynein arms (HP:0200106) | 1.90314300 |
| 109 | Arterial thrombosis (HP:0004420) | 1.90124543 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 1.85105002 |
| 111 | Clubbing of toes (HP:0100760) | 1.84366038 |
| 112 | Sepsis (HP:0100806) | 1.83049222 |
| 113 | Abnormality of T cell physiology (HP:0011840) | 1.82716100 |
| 114 | Abnormality of eosinophils (HP:0001879) | 1.81876951 |
| 115 | Conical tooth (HP:0000698) | 1.80851987 |
| 116 | Gingival bleeding (HP:0000225) | 1.79914301 |
| 117 | Prolonged bleeding time (HP:0003010) | 1.76315939 |
| 118 | Bone pain (HP:0002653) | 1.75860980 |
| 119 | Spontaneous hematomas (HP:0007420) | 1.75122837 |
| 120 | Neutropenia (HP:0001875) | 1.73109620 |
| 121 | Granulocytopenia (HP:0001913) | 1.72717638 |
| 122 | Glomerulopathy (HP:0100820) | 1.71031401 |
| 123 | Abnormality of the pleura (HP:0002103) | 1.70667564 |
| 124 | Increased cerebral lipofuscin (HP:0011813) | 1.70640284 |
| 125 | Gangrene (HP:0100758) | 1.70545956 |
| 126 | Reduced antithrombin III activity (HP:0001976) | 1.69907085 |
| 127 | Arthralgia (HP:0002829) | 1.69228944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.07579826 |
| 2 | BLK | 3.81695820 |
| 3 | IRAK4 | 3.51231782 |
| 4 | TXK | 3.44429252 |
| 5 | IRAK3 | 3.21607528 |
| 6 | FRK | 3.15304713 |
| 7 | MAP4K1 | 2.99608598 |
| 8 | SIK3 | 2.92705995 |
| 9 | RIPK4 | 2.68847894 |
| 10 | IKBKE | 2.30293683 |
| 11 | TBK1 | 2.24175970 |
| 12 | IKBKB | 2.21419478 |
| 13 | PBK | 2.13416868 |
| 14 | JAK3 | 2.12011230 |
| 15 | KIT | 2.11191522 |
| 16 | TNIK | 2.03178512 |
| 17 | TEC | 1.91019818 |
| 18 | MAP3K11 | 1.89668205 |
| 19 | ACVR1B | 1.84650519 |
| 20 | SIK2 | 1.81939443 |
| 21 | TYK2 | 1.72881395 |
| 22 | NME2 | 1.68762487 |
| 23 | MAP3K13 | 1.68320349 |
| 24 | BTK | 1.51892104 |
| 25 | SYK | 1.50079700 |
| 26 | CASK | 1.48889720 |
| 27 | EIF2AK2 | 1.45200295 |
| 28 | STK16 | 1.38628258 |
| 29 | FES | 1.37272995 |
| 30 | ADRBK2 | 1.34857212 |
| 31 | ZAP70 | 1.33583996 |
| 32 | MKNK2 | 1.32748934 |
| 33 | BMPR2 | 1.29190370 |
| 34 | CHUK | 1.25908988 |
| 35 | CLK1 | 1.25735871 |
| 36 | MARK3 | 1.25690379 |
| 37 | IRAK1 | 1.25637586 |
| 38 | LYN | 1.25619933 |
| 39 | MUSK | 1.20274756 |
| 40 | LCK | 1.18628054 |
| 41 | TESK2 | 1.18424884 |
| 42 | HCK | 1.13958131 |
| 43 | CSK | 1.13559660 |
| 44 | TAOK3 | 1.13517060 |
| 45 | YES1 | 1.13458232 |
| 46 | CSF1R | 1.12160446 |
| 47 | PIM2 | 1.09633779 |
| 48 | ITK | 1.09327000 |
| 49 | NLK | 1.08297115 |
| 50 | BMPR1B | 1.06321534 |
| 51 | JAK1 | 1.06250630 |
| 52 | DAPK2 | 1.04541425 |
| 53 | EIF2AK3 | 1.03341682 |
| 54 | IRAK2 | 1.03130235 |
| 55 | MST4 | 0.93445667 |
| 56 | PIM1 | 0.93105403 |
| 57 | GRK7 | 0.91806629 |
| 58 | MAP3K3 | 0.88259782 |
| 59 | TAOK2 | 0.87738327 |
| 60 | TAOK1 | 0.82628334 |
| 61 | NUAK1 | 0.81799578 |
| 62 | EPHB1 | 0.79471756 |
| 63 | FGR | 0.78598216 |
| 64 | MKNK1 | 0.76337043 |
| 65 | TGFBR2 | 0.76320578 |
| 66 | PKN1 | 0.75356004 |
| 67 | MAP2K6 | 0.74685620 |
| 68 | MAP3K1 | 0.73918525 |
| 69 | CDK8 | 0.73103207 |
| 70 | PRPF4B | 0.72743708 |
| 71 | CDC42BPA | 0.71685384 |
| 72 | INSRR | 0.70704653 |
| 73 | ZAK | 0.69286958 |
| 74 | PDK1 | 0.69252965 |
| 75 | STK4 | 0.69228691 |
| 76 | PRKCQ | 0.69001196 |
| 77 | PIK3CG | 0.67190956 |
| 78 | MAPK11 | 0.64532892 |
| 79 | BCKDK | 0.64395382 |
| 80 | EPHA3 | 0.60328879 |
| 81 | ADRBK1 | 0.60263397 |
| 82 | GRK1 | 0.59849072 |
| 83 | CDK19 | 0.58477532 |
| 84 | RPS6KA4 | 0.58114802 |
| 85 | TRPM7 | 0.56829949 |
| 86 | MAP3K7 | 0.56066296 |
| 87 | TNK2 | 0.55652717 |
| 88 | TLK1 | 0.55434383 |
| 89 | MAPK12 | 0.54087607 |
| 90 | CDK3 | 0.53260643 |
| 91 | STK10 | 0.51371070 |
| 92 | PDPK1 | 0.50660144 |
| 93 | CAMKK2 | 0.50411823 |
| 94 | PTK2B | 0.49180458 |
| 95 | MAPK7 | 0.48572949 |
| 96 | ABL1 | 0.48374331 |
| 97 | PRKD2 | 0.47425106 |
| 98 | RPS6KA5 | 0.47296244 |
| 99 | PRKCD | 0.46767503 |
| 100 | TGFBR1 | 0.45718536 |
| 101 | SRPK1 | 0.45412474 |
| 102 | MARK2 | 0.43526592 |
| 103 | KDR | 0.42407613 |
| 104 | RPS6KC1 | 0.41423604 |
| 105 | RPS6KL1 | 0.41423604 |
| 106 | FLT3 | 0.40801094 |
| 107 | BRD4 | 0.39177287 |
| 108 | CDK4 | 0.37544725 |
| 109 | MST1R | 0.36698050 |
| 110 | ABL2 | 0.36066209 |
| 111 | MAPKAPK3 | 0.35857594 |
| 112 | SIK1 | 0.35785787 |
| 113 | PRKAA2 | 0.33630244 |
| 114 | MAPK13 | 0.32404963 |
| 115 | JAK2 | 0.30975684 |
| 116 | MAP3K5 | 0.29862340 |
| 117 | VRK1 | 0.28704264 |
| 118 | HIPK2 | 0.27885557 |
| 119 | MAP2K2 | 0.26873661 |
| 120 | MAPK3 | 0.26763617 |
| 121 | NEK9 | 0.26090371 |
| 122 | MATK | 0.25940793 |
| 123 | MAP3K12 | 0.24986910 |
| 124 | CDK9 | 0.24800628 |
| 125 | MAPK15 | 0.24399654 |
| 126 | MAPKAPK2 | 0.23493665 |
| 127 | FYN | 0.23408375 |
| 128 | ERN1 | 0.22433999 |
| 129 | NEK6 | 0.21809681 |
| 130 | RPS6KA6 | 0.21538705 |
| 131 | GRK6 | 0.21025596 |
| 132 | MAP2K3 | 0.19215939 |
| 133 | INSR | 0.18995666 |
| 134 | BMX | 0.18759755 |
| 135 | MAPK4 | 0.18701792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.99187257 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.87527972 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.86504954 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.67355245 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.62768146 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.56585396 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.44807789 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.31284387 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26417212 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.20151354 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.12766203 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06209433 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05818673 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04528075 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02135450 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00753091 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.96908939 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86570333 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.77623943 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.67604644 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65309033 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62362001 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.60155280 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60087274 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55339132 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.54275881 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50929955 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50245189 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45433317 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42903068 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42833755 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.42020302 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.36307954 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21223516 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.18151861 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16958650 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.13252931 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13114242 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09690765 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.09346693 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08716441 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08453981 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06803338 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.04793086 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99544863 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.93995349 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92338826 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.91213403 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88439858 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88062383 |
| 51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88031715 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 0.84734883 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84235214 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83145736 |
| 55 | Protein export_Homo sapiens_hsa03060 | 0.79081256 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77187293 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76930492 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.76888900 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75079665 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74197154 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72322881 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70880887 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70589555 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67996542 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63328754 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62622193 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61132722 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60924242 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60468819 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59333899 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53626900 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.52859224 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.51091820 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49283716 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48478456 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48236048 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47796133 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45616785 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45232888 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44287372 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44164337 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43141778 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42934739 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.42019574 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41889933 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40823371 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38379929 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38374948 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37535000 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.36392449 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36177028 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35287847 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.34742108 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32892053 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32813890 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32037169 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.29897050 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29654360 |
| 99 | DNA replication_Homo sapiens_hsa03030 | 0.27686773 |
| 100 | RNA polymerase_Homo sapiens_hsa03020 | 0.27513165 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.26756859 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26571891 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26165060 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24795984 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24576586 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24358085 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.24230114 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24200067 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24170134 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23743512 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23713210 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23470334 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23220059 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23053224 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22973557 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22944573 |
| 117 | Melanoma_Homo sapiens_hsa05218 | 0.22341331 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.21180162 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21163233 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20079990 |
| 121 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19620941 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18935389 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.18639306 |

